drugset / Trial / NCT07118332

Psilocybin as a Treatment for Chronic Pain in Smokers

NCT07118332

Phase 0 Not yet recruiting 10 enrolled Yale University
NaSingle-groupOpen-labelHealth-services research

Summary

The purpose of this study is to understand whether psilocybin therapy is safe and well tolerated in improving chronic pain and increasing motivation to quit smoking for people who have chronic pain and smoke cigarettes. Psilocybin is a psychedelic drug and the active ingredient in "magic mushrooms." Psilocybin is currently being studied in clinical trials but has no current medical use in the United States. Some studies have shown that a dose of psilocybin can help people quit smoking. Other studies have shown that a dose of psilocybin may improve certain chronic pain conditions, such as migraine headaches. We believe that it may also be helpful for people who smoke and have chronic pain, but this has not been tested yet.

Timeline

Start
2026-07
Primary completion
2027-10-01
Completion
2027-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Psilocybin Other / unclassified 25 mg Oral

Indications

No indication recorded.